| 标题 |
Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者:Wermke M; Gambardella V; Kuboki Y; Felip E; Sanmamed MF; et al 出版日期:2025/09/20 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)